🇺🇸 FDA
Patent

US 6878686

Cross-linked glycopeptide-cephalosporin antibiotics

expired A61KA61K38/00A61P

Quick answer

US patent 6878686 (Cross-linked glycopeptide-cephalosporin antibiotics) held by Theravance, Inc. expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/00, A61P, A61P31/00, A61P31/04